Characterizing the conversion kinetics of carbamazepine polymorphs to the dihydrate in aqueous suspension using Raman spectroscopy.

[1]  C Vervaet,et al.  Development and validation of a direct, non-destructive quantitative method for medroxyprogesterone acetate in a pharmaceutical suspension using FT-Raman spectroscopy. , 2004, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[2]  Peter York,et al.  Use of in situ FT-Raman spectroscopy to study the kinetics of the transformation of carbamazepine polymorphs. , 2004, Journal of pharmaceutical and biomedical analysis.

[3]  Giancarlo Fini,et al.  Applications of Raman spectroscopy to pharmacy , 2004 .

[4]  Thomas Rades,et al.  Quantitative analysis of polymorphic mixtures of carbamazepine by Raman spectroscopy and principal components analysis , 2004 .

[5]  J. H. T. Horst,et al.  Quantitative Measurement of the Polymorphic Transformation of l-Glutamic Acid Using In-Situ Raman Spectroscopy , 2004 .

[6]  H. Brittain.  Fluorescence studies of the transformation of carbamazepine anhydrate form III to its dihydrate phase. , 2004, Journal of pharmaceutical sciences.

[7]  Ulrich J. Griesser,et al.  Qualitative and quantitative study of polymorphic forms in drug formulations by near infrared FT-Raman spectroscopy , 2003 .

[8]  B. Glennon,et al.  In Situ Monitoring of Polymorphic Transitions , 2003 .

[9]  A. Matzger,et al.  Comparison of the four anhydrous polymorphs of carbamazepine and the crystal structure of form I. , 2003, Journal of pharmaceutical sciences.

[10]  T. Vickers,et al.  Effect of Powder Properties on the Intensity of Raman Scattering by Crystalline Solids , 2002 .

[11]  Jean Paul Remon,et al.  Applications of Raman spectroscopy in pharmaceutical analysis , 2002 .

[12]  K. Gordon,et al.  Quantitative analysis of polymorphic mixtures of ranitidine hydrochloride by Raman spectroscopy and principal components analysis. , 2002, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[13]  George Zhou,et al.  Process Optimization of a Complex Pharmaceutical Polymorphic System via In Situ Raman Spectroscopy , 2002 .

[14]  N. Rodríguez-Hornedo,et al.  Solution-mediated phase transformation of anhydrous to dihydrate carbamazepine and the effect of lattice disorder. , 2002, International journal of pharmaceutics.

[15]  Y. Kawashima,et al.  Improved Inhalation Behavior of Steroid KSR-592 in Vitro with Jethaler® by Polymorphic Transformation to Needle-Like Crystals (β-Form) , 2002, Pharmaceutical Research.

[16]  J. Rantanen,et al.  Hydrate Formation During Wet Granulation Studied by Spectroscopic Methods and Multivariate Analysis , 2002, Pharmaceutical Research.

[17]  Joel Bernstein,et al.  Polymorphism in Molecular Crystals , 2002 .

[18]  Steven W Booth,et al.  Quantitative analysis of mannitol polymorphs. FT-Raman spectroscopy. , 2002, Journal of pharmaceutical and biomedical analysis.

[19]  T. Ona,et al.  Non-destructive method for the quantification of the average particle diameter of latex as water-based emulsions by near-infrared Fourier transform Raman spectroscopy , 2002 .

[20]  A. Matzger,et al.  Form IV of carbamazepine. , 2002, Journal of pharmaceutical sciences.

[21]  L. S. Taylor,et al.  Evaluation of solid-state forms present in tablets by Raman spectroscopy. , 2000, Journal of pharmaceutical sciences.

[22]  J. A. Wachter,et al.  An Investigation of Solvent-Mediated Polymorphic Transformation of Progesterone Using in Situ Raman Spectroscopy , 2000 .

[23]  Alan G. Ryder,et al.  Quantitative analysis of cocaine in solid mixtures using Raman spectroscopy and chemometric methods , 2000 .

[24]  H. Al-Zein,et al.  Effect of packaging and storage on the stability of carbamazepine tablets. , 1999, Drug development and industrial pharmacy.

[25]  G. Zografi,et al.  The Quantitative Analysis of Crystallinity Using FT-Raman Spectroscopy , 1998, Pharmaceutical Research.

[26]  D. Bugay,et al.  Utilization of Fourier transform-Raman spectroscopy for the study of pharmaceutical crystal forms. , 1998, Journal of pharmaceutical and biomedical analysis.

[27]  A. Dzyabchenko,et al.  X-ray characterization of the triclinic polymorph of carbamazepine. , 1997, Journal of pharmaceutical sciences.

[28]  J. Sjöblom,et al.  Quantitative FT-Raman analysis of two crystal forms of a pharmaceutical compound. , 1997, Journal of pharmaceutical and biomedical analysis.

[29]  P. York,et al.  Characterization of dihydrates prepared from carbamazepine polymorphs. , 1996, Journal of pharmaceutical sciences.

[30]  G. Nilsson,et al.  Quantitative determination of sulfasalazine by near-infrared spectroscopy and multivariate analysis in reflectance mode with a fibre-optic probe. , 1995, Journal of pharmaceutical and biomedical analysis.

[31]  G. Shiu,et al.  Reduced Bioavailability of Moisture‐Exposed Carbamazepine Resulting in Status Epilepticus , 1993, Epilepsia.

[32]  Vinod P. Shah,et al.  The Bioinequivalence of Carbamazepine Tablets with a History of Clinical Failures , 1992, Pharmaceutical Research.

[33]  M. Lowes.  More information on hardening of carbamazepine tablets. , 1991, American journal of hospital pharmacy.

[34]  R. Suryanarayanan,et al.  Kinetics of transition of anhydrous carbamazepine to carbamazepine dihydrate in aqueous suspensions. , 1991, Journal of pharmaceutical sciences.

[35]  R. Suryanarayanan.  Determination of the Relative Amounts of Anhydrous Carbamazepine (C15H12N2O) and Carbamazepine Dihydrate (C15H12N2O · 2H2O) in a Mixture by Powder X-ray Diffractometry , 1989, Pharmaceutical Research.

[36]  A. P. Lötter,et al.  Physicochemical properties and X-ray structural studies of the trigonal polymorph of carbamazepine. , 1987, Journal of pharmaceutical sciences.

[37]  E. Laine,et al.  Formation of dihydrate from carbamazepine anhydrate in aqueous conditions , 1984 .

[38]  O. W. Richards,et al.  The merck Index , 1978 .

[39]  E. Salje.  Experimentelle Untersuchung der Ramanstreuung an Kristallpulvern , 1973 .

[40]  H. Wikström,et al.  In-line monitoring of hydrate formation during wet granulation using Raman spectroscopy. , 2005, Journal of pharmaceutical sciences.

[41]  I. Hunter,et al.  Laser Raman spectroscopic analysis of polymorphic forms in microliter fluid volumes. , 2003, Journal of pharmaceutical sciences.

[42]  M. Otsuka,et al.  Effect of surface-modification on hydration kinetics of nitrofurantoin anhydrate , 2002 .

[43]  Hoeil Chung,et al.  Compositional Analysis of Naphtha by FT-Raman Spectroscopy , 1999 .

[44]  Y. D. West,et al.  Quantitative FT Raman analysis of two component systems , 1997 .

[45]  J. Rouland,et al.  Polymorphism of carbamazepine: solid-state studies on carbamazepine dihydrate. , 1991, Pharmaceutica acta Helvetiae.

[46]  F. Krahn,et al.  Relations between several polymorphic forms and the dihydrate of carbamazepine. , 1987, Pharmaceutica acta Helvetiae.